Data-driven. Obsessive. A little pushy. Meet this year's Top 40 Healthcare Transformers

Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.

Will the real patient advocate please stand up?

Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare comms ought to have something to say about that.

Purdue's Point of No Return

Purdue's decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?

MM&M's Data Week: Demystifying one of pharma's biggest pain points

It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.

CVS/Aetna Combo a Formidable Pharma Rival When it Comes to Access

The combined company wields greater power to disrupt brand profits.

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

Technology like this could expand further to form better collaborations between pharma, payers and organized providers.

Memo to New CEOs: Prioritize Diversity

Management turnover has brought the opportunity to keep up the pressure.

Snubbing Intolerance: Frazier's Path Was Disengagement

Merck CEO Kenneth Frazier's exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.

Gender Parity: A Known Quantity That's Being Ignored

Our goal is to make gender parity a priority, and to keep our spotlight trained on it.

Agencies, Get Ready for a Dose of Clarity

Welcome to what may be the most comprehensive MM&M Agency Top 100 ever.